New Research PapersFocus on Coronary PharmacotherapyEffect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
Focus on Coronary Pharmacotherapy
Under an Elsevier user license
open archive
Central Illustration
Key Words
clopidogrel
CYP2C19 genotype
ischemic outcomes
meta-analysis
prasugrel
systematic review
ticagrelor
Abbreviations and Acronyms
ACS
acute coronary syndrome(s)
BARC
Bleeding Academic Research Consortium
CAD
coronary artery disease
CI
confidence interval
CV
cardiovascular
FDA
U.S. Food and Drug Administration
HR
hazard ratio
LOF
loss-of-function
PCI
percutaneous coronary intervention
RCT
randomized controlled trial
RR
relative risk
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 the American College of Cardiology Foundation. Published by Elsevier.